Credit: Canva
Low-dose CT chest scans could help detect pneumonia in at-risk patients while exposing them to only small amounts of radiation, a new study has found. The research, published in Radiology: Cardiothoracic Imaging, shows that ultra-low-dose scans can effectively detect pneumonia in patients with compromised immune systems, enabling doctors to treat the infection before it becomes life-threatening. According to the researchers, these scans expose patients to just 2% of the radiation dose used in a standard CT scan.
"This study paves the way for safer, AI-driven imaging that reduces radiation exposure while preserving diagnostic accuracy,” lead researcher Dr Maximiliano Klug, a radiologist with the Sheba Medical Center in Ramat Gan, Israel, said in a news release. He added that CT scans are the gold standard for detecting pneumonia but there are concerns regarding the risk posed by repeated exposure to radiation. There is a solution- ultra-low-dose CT scan. However, the problem is that these scans can be grainy and hard to read, researchers said.
Study Gives Solution To This
To overcome that, Klug's team developed an AI program that could help "de-noise" low-dose scans, making them sharper and easier to read. Between September 2020 and December 2022, 54 patients with compromised immune systems who had fevers underwent a pair of chest CT scans -- a normal dose scan and an ultra-low-dose scan. The AI program cleaned up the low-dose scan, and then both sets of images were given to a pair of radiologists for assessment. Radiologists had 100% accuracy in detecting pneumonia and other lung problems with the AI-cleaned low-dose scans, but 91% to 98% accuracy in examining the scans that hadn’t been improved through AI, results show.
"This pilot study identified infection with a fraction of the radiation dose," Klug said. "This approach could drive larger studies and ultimately reshape clinical guidelines, making denoised ultra-low dose CT the new standard for young immunocompromised patients.
How Can You Detect Pneumonia?
Pneumonia is a lung infection that causes the air sacs in the lungs to fill with fluid or pus and can be caused by bacteria, viruses, or fungi. The symptoms can range from milk to severe, which includes:
Coughing with or without cough
Fever
Chills
Trouble breathing
Chest pain, especially when breathing deeply or coughing
Sweating or chills
Rapid heart rate
Loss of appetite
Bluish skin, lips, and nails
Confusion.
How to detect Pneumonia in coughing newborns and toddlers?
Pneumonia can severely affect newborns and young children as their lungs are comparatively more sensitive. As per Dr Goyal, young children can cough for various reasons including seasonal infections and tonsillitis, which is very common in this age group. But if they look visibly irritable and have poor sleep patterns, then parents must reach out to an expert. "I am not saying that parents must visit a hospital but any local paediatrician would be able to detect pneumonia in your kid.
Credits: AP
Alex Singleton, American football linebacker has undergone a surgery on Friday to have a cancerous tumor removed from one of his testicles. He told this to his teammates and coaches in an emotional team meeting on Monday morning. His family and few of his close friends, including some team officials were the only ones who knew.
"Cancer is a scary word, still is, still freaks me out just saying it," he said to one of the local reporters, as reported by ESPN.
His diagnosis came in ways one would not expect. Before the Houston Texans game on Wednesday, Singleton, 31, was to take the league-mandated random drug test, which showed that he had elevated levels of hormone hCG in his system. He said that he knew he was not taking hCG. This is what led him to make an appointment with a urologist and then he underwent several tests. He also underwent a CT scan and ultrasound scan and received the notice last Monday that a tumor on his testicle was cancerous. After this, his surgery was scheduled.
However, he told his doctors that he wanted to play in Thursday night's game against the Las Vegas Raiders.
As per the Urology Care Foundation and the American Urological Association, testicular cancer happens when cells in the testicle grow to form a tumor. Though this is rare, more than 90% of testicular cancers begin in the germ cell, which produce sperm.
There are two types of germ cell cancers (GCTs). Seminoma can grow slowly and respond very well to radiation and chemotherapy. Non-seminoma can grow more quickly and can be less responsive to those treatments. There are a few types of non-seminomas: choriocarcinoma, embryonal carcinoma, teratoma and yolk sac tumors.
There are also rare testicular cancers that don’t form in the germ cells.
Some of the symptoms of testicular cancer could be difficult to note at first, however, there are symptoms that one should note for:
The Urology Care Foundation notes that around 75 of 100 men who have swelling or a lump in their testicles have cancer. Most masses in the scrotum outside of the testicle are not cancer, however, you must tell your doctor if you do detect a lump.
The longer you wait the more chances are for the cancer to grow and spread.
The risk of testicle cancer rises for men with
Yes, you can. The process is to first be relaxed, then to firmly roll each testicle between the thumb and forefingers to check for any lumps or if any of the testis feel larger than the other. See if you feel any lump or pain around the area. Make it a habit, and look for any changes in size, shape or texture.
Credits: AP, FDA
US Secretary of Health and Human Services Robert F Kennedy Jr has announced the new plans of the Food and Drug Administration (FDA) to remove the "black box" warning on the hormone treatments used by women with menopause symptoms. This is the big, lengthy, physical black box on the label of the menopause hormone therapy that includes the risks like cardiovascular disease, stroke, breast cancer, and dementia. FDA is now saying that it will take away the black box warning.
This is based on a 2002 study, as quoted by RFK Jr too that warns that the use of menopause hormone therapy could raise the risk of all the conditions mentioned inside the black box.
However, since then, it was found that some of those risks, mentioned on the label, were, in fact, misrepresented and overstated. It was found that within the 10 years of menopause onset, this therapy could really be beneficial, reports CNN. It was found that the therapy would not only prevent women from hot flashes and night sweats, which are the typical symptoms of menopause, but it would also benefit them in the long run, by protecting from bone fractures.
The FDA hopes to remove this label starting in the next few months, with the hope that it would also remove the fear around women into using these therapy treatment.
The CNN reported that while the new label will still have some of those warning, however, it won't be the "absolute, strongest warning" on the label that is the first thing the women see.
As per the Cleveland Clinic, hormone replacement therapy or HRT, is a treatment that helps people with symptoms of menopause.
Healthcare providers also call it hormone therapy (HT), especially when you receive it after age 50. Hormone replacement therapy or HRT is the term providers use when you receive the treatment at a younger age, especially before age 40.
When you’re moving into menopause, your ovaries naturally slow down and produce much less estrogen. That drop can trigger a bunch of uncomfortable symptoms, like:
Hormone replacement therapy (HRT) basically gives your body back the hormones it’s no longer making enough of. Once those levels stabilize, many people feel a lot better. HRT can also help protect your bones, since low estrogen is linked to conditions like osteoporosis and osteopenia.
That said, HRT isn’t a one-size-fits-all solution. Whether it’s right for you is something worth discussing with your healthcare provider. It can ease symptoms, but it also comes with its own risks. A good, honest conversation about the pros and cons will help you figure out what’s best for your body.
Hormone therapy (HT) is a broader term that implies to any type of treatment involving hormones. It could include any therapy involving hormone, including hormone therapy for cancer, or to treat certain hormone imbalances. However, hormone replacement therapy (HRT) usually means the hormones are replacing the natural hormones your body is no longer making, especially for people in their 30s or early 40s.
There are two types of HRT, estrogen therapy and combination therapy, which means a combination of estrogen and progesterone.
Credits: Canva
Hormone Replacement Therapy: The U.S. FDA has announced it will remove the long-standing black box safety warnings from all hormone replacement therapy (HRT) products used to manage menopause and perimenopause symptoms. The move comes after new evidence suggested that earlier studies overstated the risks of heart disease, stroke, and cancer linked to HRT.
The U.S. Food and Drug Administration (FDA) has announced that it will remove the black box safety warnings from all forms of hormone replacement therapy (HRT)—including creams, pills, and other treatments used to manage menopause and perimenopause symptoms.
The warnings, which appeared on labels for over two decades, suggested that these therapies could increase the risk of cancers, dementia, heart disease, and strokes. However, FDA Commissioner Dr. Marty Makary told CBS News that those cautions likely discouraged many women from using treatments that might actually improve their long-term health.
“We now have a more nuanced understanding,” Dr. Makary said, as per CNN News. He further said, “We want to put that fear in context and let people know that there are tremendous long-term health benefits.”
HRT, or Hormone Replacement Therapy, is a treatment that helps restore hormones the body no longer produces in sufficient amounts. It is most often prescribed to ease menopause symptoms such as hot flashes by supplementing estrogen and progesterone, the hormones that naturally decline during this stage. According to the NHS, HRT may also be recommended for other hormonal deficiencies, including those caused by thyroid or pituitary gland disorders.
Removing the black box warning signals a significant shift in how hormone replacement therapy is viewed by regulators and the medical community. The decision suggests that the potential benefits of properly prescribed HRT now outweigh the earlier perceived risks.
It also means that doctors may feel more confident recommending these treatments for women struggling with menopause symptoms such as hot flashes, mood changes, and vaginal dryness—especially when therapy is started around the time of menopause rather than years later.
However, experts still stress that hormone replacement therapy is not one-size-fits-all. Women should discuss their personal and family medical history with their doctor to decide whether HRT is the right choice for them.
In 2002, the landmark Women’s Health Initiative study linked hormone therapy to higher rates of breast cancer and stroke, prompting the FDA to issue the now-familiar black box warning—the strongest alert it can give.
But since then, newer research has challenged those early conclusions. Studies now show that hormone replacement therapy, particularly when started early, may reduce the risk of heart disease, improve bone health, and even protect against cognitive decline.
This shift in scientific understanding pushed many doctors to call for the warning’s removal, arguing that the outdated label created unnecessary fear and confusion among women seeking menopause relief.
As per USA Today, in July, the FDA organized an expert panel to evaluate whether the warnings should remain, especially for low-dose vaginal estrogen products. After the meeting, the agency opened a public comment period and received nearly 3,000 responses by late September.
The American College of Obstetricians and Gynecologists (ACOG) has long supported reviewing the label on low-dose vaginal estrogen, which acts locally rather than systemically. However, ACOG also raised concerns that the July panel lacked the depth and transparency of a standard FDA advisory committee meeting.
“A two-hour expert panel should not replace a full advisory committee discussion,” ACOG stated in its formal comment, urging the FDA to hold separate, detailed reviews for vaginal and systemic hormone therapy options.
Despite these reservations, the FDA shared several supporting studies, including evidence that hormone replacement therapy can reduce the risk of Alzheimer’s disease, heart attack, and hip fractures. Many of these findings date back to research published between the 1980s and early 2000s.
The FDA’s decision to drop the black box warning from menopause-related hormone treatments marks a turning point in women’s health care. As research continues to clarify the true risks and benefits of hormone replacement therapy, the move could help many women make more informed and less fearful decisions about managing menopause safely and effectively.
© 2024 Bennett, Coleman & Company Limited